SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950156-13-000039
Filing Date
2013-05-03
Accepted
2013-05-03 10:05:13
Documents
5
Period of Report
2013-05-22
Effectiveness Date
2013-05-03

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY MATERIAL d900917_igidef14a.htm DEF 14A 216890
2 d900917_igidef14a001.jpg GRAPHIC 14898
3 d900917_igidef14a002.jpg GRAPHIC 14898
4 d900917_igidef14a003.jpg GRAPHIC 4096
5 d900917_igidef14a004.jpg GRAPHIC 4103
  Complete submission text file 0000950156-13-000039.txt   271004
Mailing Address 105 LINCOLN AVENUE BUENA NJ 08310
Business Address 105 LINCOLN AVENUE BUENA NJ 08310 6096971441
IGI LABORATORIES, INC (Filer) CIK: 0000352998 (see all company filings)

IRS No.: 010355758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-08568 | Film No.: 13810685
SIC: 2836 Biological Products, (No Diagnostic Substances)